Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Murray A Goldberg. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Murray A Goldberg har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:AYLA / Ayala Pharmaceuticals Inc | Director | 6 250 |
US:AERI / Aerie Pharmaceuticals Inc | Director | 0 |
US:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) | Director | 17 621 |
US:REGN / Regeneron Pharmaceuticals, Inc. | SVP Administration & Asst Secr | 78 079 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Murray A Goldberg. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Murray A Goldberg som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-06-14 |
|
4 | AYLA |
Ayala Pharmaceuticals, Inc.
Stock Option (Right to Buy) |
A - Award | 6 250 | 6 250 | |||||
2020-05-20 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Stock Option (right to buy) |
M - Exercise | −28 000 | 0 | −100,00 | ||||
2020-05-20 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
M - Exercise | 28 000 | 36 050 | 347,83 | 3,15 | 88 200 | 113 558 | |
2019-06-13 |
|
4 | TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units |
A - Award | 17 621 | 17 621 | |||||
2019-05-24 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 7 800 | 7 800 | |||||
2019-05-24 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
A - Award | 1 750 | 8 050 | 27,78 | ||||
2018-06-08 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 7 800 | 7 800 | |||||
2018-06-08 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
A - Award | 1 750 | 6 300 | 38,46 | ||||
2018-06-07 |
|
4 | TEVA |
TEVA PHARMACEUTICAL INDUSTRIES LTD
Restricted Share Units |
A - Award | 6 041 | 6 041 | |||||
2017-06-09 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2017-06-09 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
A - Award | 1 150 | 4 550 | 33,82 | ||||
2016-06-09 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2016-06-09 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
A - Award | 1 700 | 3 400 | 100,00 | ||||
2015-04-14 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Stock Option (right to buy) |
A - Award | 10 000 | 10 000 | |||||
2015-04-14 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Common Stock |
A - Award | 1 700 | 1 700 | |||||
2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 60 000 | 78 079 | 331,88 | ||||
2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −3 264 | 0 | −100,00 | ||||
2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 264 | 64 436 | 5,34 | 30,63 | 99 976 | 1 973 675 | |
2014-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −1 930 | 61 172 | −3,06 | ||||
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 035 | 63 102 | −1,61 | 404,18 | −418 326 | 25 504 566 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 454 | 64 137 | −3,69 | 403,50 | −990 189 | 25 879 280 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 500 | 66 591 | −3,62 | 402,54 | −1 006 350 | 26 805 541 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 293 | 69 091 | −7,12 | 401,51 | −2 125 192 | 27 740 727 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 531 | 74 384 | −9,19 | 400,51 | −3 016 241 | 29 791 536 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 200 | 81 915 | −3,76 | 399,37 | −1 277 984 | 32 714 394 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 100 | 85 115 | −2,41 | 398,58 | −837 018 | 33 925 137 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 700 | 87 215 | −1,91 | 397,65 | −676 005 | 34 681 045 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −775 | 88 915 | −0,86 | 396,80 | −307 520 | 35 281 472 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 89 690 | −0,22 | 395,96 | −79 192 | 35 513 652 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −60 000 | 6 736 | −89,91 | |||
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −28 523 | 89 890 | −24,09 | 391,93 | −11 179 019 | 35 230 588 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −4 689 | 118 413 | −3,81 | 391,93 | −1 837 760 | 46 409 607 |
2014-10-27 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 60 000 | 123 102 | 95,08 | 30,63 | 1 837 800 | 3 770 614 |
2014-06-13 |
|
4 | AERI |
AERIE PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 13 500 | 13 500 | |||||
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 63 102 | −0,47 | 346,73 | −104 019 | 21 879 356 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 63 402 | −0,16 | 345,02 | −34 502 | 21 874 958 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 63 502 | −0,31 | 344,47 | −68 894 | 21 874 534 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 63 702 | −0,78 | 342,19 | −171 095 | 21 798 187 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 100 | 64 202 | −3,17 | 341,46 | −717 066 | 21 922 415 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 66 302 | −1,78 | 340,43 | −408 516 | 22 571 190 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 300 | 67 502 | −1,89 | 339,20 | −440 960 | 22 896 678 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 934 | 68 802 | −5,41 | 338,37 | −1 331 148 | 23 280 533 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 962 | 72 736 | −2,63 | 337,40 | −661 979 | 24 541 126 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −275 | 74 698 | −0,37 | 336,89 | −92 645 | 25 165 009 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 893 | 0 | −100,00 | |||
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −6 334 | 0 | −100,00 | |||
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −20 000 | 18 079 | −52,52 | |||
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 479 | 74 973 | −1,93 | 342,63 | −506 750 | 25 687 999 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 023 | 76 452 | −1,32 | 342,63 | −350 510 | 26 194 749 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 893 | 77 475 | 5,29 | 90,07 | 350 643 | 6 978 173 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −8 747 | 73 582 | −10,62 | 342,63 | −2 996 985 | 25 211 401 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −3 036 | 82 329 | −3,56 | 342,63 | −1 040 225 | 28 208 385 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 85 365 | 30,60 | 52,03 | 1 040 600 | 4 441 541 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −2 407 | 65 365 | −3,55 | 342,63 | −824 710 | 22 396 010 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 664 | 67 772 | −2,40 | 342,63 | −570 136 | 23 220 720 |
2014-02-26 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 334 | 69 436 | 10,04 | 90,07 | 570 503 | 6 254 101 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 203 | 63 102 | −3,37 | 339,31 | −747 500 | 21 411 140 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 204 | 65 305 | −7,38 | 338,51 | −1 761 606 | 22 106 396 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 126 | 70 509 | −2,93 | 337,51 | −717 546 | 23 797 493 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 158 | 72 635 | −5,41 | 336,42 | −1 398 834 | 24 435 867 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 143 | 76 793 | −3,93 | 335,67 | −1 055 011 | 25 777 106 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 824 | 79 936 | −3,41 | 334,45 | −944 487 | 26 734 595 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 82 760 | −0,36 | 333,90 | −100 170 | 27 633 564 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 83 060 | −0,48 | 332,67 | −133 068 | 27 631 570 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 83 460 | −0,60 | 328,50 | −164 250 | 27 416 610 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 83 960 | −0,47 | 327,84 | −131 136 | 27 525 446 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −10 424 | 0 | −100,00 | |||
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −4 168 | 0 | −100,00 | |||
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −2 976 | 0 | −100,00 | |||
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 084 | 0 | −100,00 | |||
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −30 000 | 66 736 | −31,01 | |||
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −996 | 84 360 | −1,17 | 326,05 | −324 746 | 27 505 578 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −535 | 85 356 | −0,62 | 326,05 | −174 437 | 27 830 324 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 084 | 85 891 | 3,72 | 56,61 | 174 585 | 4 862 290 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 225 | 82 807 | −1,46 | 326,05 | −399 411 | 26 999 222 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −600 | 84 032 | −0,71 | 326,05 | −195 630 | 27 398 634 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 976 | 84 632 | 3,64 | 65,76 | 195 702 | 5 565 400 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 670 | 81 656 | −2,00 | 326,05 | −544 504 | 26 623 939 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −927 | 83 326 | −1,10 | 326,05 | −302 248 | 27 168 442 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 168 | 84 253 | 5,20 | 72,60 | 302 597 | 6 116 768 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −4 064 | 80 085 | −4,83 | 326,05 | −1 325 067 | 26 111 714 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −2 542 | 84 149 | −2,93 | 326,05 | −828 819 | 27 436 781 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 424 | 86 691 | 13,67 | 79,53 | 829 021 | 6 894 535 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −14 017 | 76 267 | −15,53 | 326,05 | −4 570 243 | 24 866 855 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −2 818 | 90 284 | −3,03 | 326,05 | −918 809 | 29 437 098 |
2014-02-24 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 93 102 | 47,54 | 30,63 | 918 900 | 2 851 714 |
2013-12-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −4 705 | 0 | −100,00 | ||||
2013-12-19 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 705 | 63 102 | 8,06 | 21,25 | 99 981 | 1 340 918 | |
2013-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −5 157 | 58 397 | −8,11 | 272,73 | −1 406 469 | 15 926 614 |
2013-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2013-12-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 60 000 | 96 736 | 163,33 | ||||
2013-08-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2013-08-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 000 | 63 554 | 8,54 | 16,80 | 84 000 | 1 067 707 | |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −3 071 | 0 | −100,00 | ||||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −952 | 5 000 | −15,99 | ||||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 000 | 58 554 | −4,87 | 264,61 | −793 830 | 15 493 974 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 200 | 61 554 | −3,45 | 263,89 | −580 558 | 16 243 485 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 910 | 63 754 | −2,91 | 262,14 | −500 687 | 16 712 474 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 774 | 65 664 | −11,79 | 261,36 | −2 293 173 | 17 161 943 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −18 542 | 74 438 | −19,94 | 260,57 | −4 831 489 | 19 396 310 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 566 | 92 980 | −8,44 | 259,48 | −2 222 706 | 24 126 450 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 989 | 101 546 | −8,13 | 258,54 | −2 324 016 | 26 253 703 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 516 | 110 535 | −3,08 | 257,59 | −905 686 | 28 472 711 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 561 | 114 051 | −7,73 | 256,61 | −2 453 448 | 29 266 627 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 777 | 123 612 | −1,42 | 255,52 | −454 059 | 31 585 338 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 919 | 0 | −100,00 | |||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 750 | 4 670 | −44,54 | |||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −15 000 | 8 420 | −64,05 | |||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −6 250 | 23 420 | −21,07 | |||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −50 000 | 29 670 | −62,76 | |||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −20 000 | 0 | −100,00 | |||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −16 250 | 40 000 | −28,89 | |||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −12 798 | 56 250 | −18,53 | |||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 3 071 | 125 389 | 2,51 | 20,32 | 62 403 | 2 547 904 | |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 952 | 122 318 | 0,78 | 16,80 | 15 994 | 2 054 942 | |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −4 061 | 121 366 | −3,24 | ||||
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −9 116 | 125 427 | −6,78 | 266,64 | −2 430 690 | 33 443 855 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 260 | 134 543 | −0,93 | 266,64 | −335 966 | 35 874 546 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 135 803 | 17,27 | 16,80 | 336 000 | 2 281 490 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −9 664 | 115 803 | −7,70 | 266,64 | −2 576 809 | 30 877 712 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 260 | 125 467 | −0,99 | 266,64 | −335 966 | 33 454 521 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 20 000 | 126 727 | 18,74 | 16,80 | 336 000 | 2 129 014 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −7 852 | 106 727 | −6,85 | 266,64 | −2 093 657 | 28 457 687 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 023 | 114 579 | −0,88 | 266,64 | −272 773 | 30 551 345 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 16 250 | 115 602 | 16,36 | 16,80 | 273 000 | 1 942 114 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 617 | 99 352 | −1,60 | 266,64 | −431 157 | 26 491 217 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −781 | 100 969 | −0,77 | 266,64 | −208 246 | 26 922 374 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 919 | 101 750 | 4,01 | 53,18 | 208 412 | 5 411 065 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −6 184 | 97 831 | −5,95 | 266,64 | −1 648 902 | 26 085 658 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −806 | 104 015 | −0,77 | 266,64 | −214 912 | 27 734 560 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 798 | 104 821 | 13,91 | 16,80 | 215 006 | 1 760 993 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 779 | 92 023 | −1,90 | 266,64 | −474 353 | 24 537 013 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −298 | 93 802 | −0,32 | 266,64 | −79 459 | 25 011 365 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 750 | 94 100 | 4,15 | 21,25 | 79 688 | 1 999 625 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −7 119 | 90 350 | −7,30 | 266,64 | −1 898 210 | 24 090 924 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 195 | 97 469 | −1,21 | 266,64 | −318 635 | 25 989 134 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 98 664 | 17,93 | 21,25 | 318 750 | 2 096 610 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −2 966 | 83 664 | −3,42 | 266,64 | −790 854 | 22 308 169 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −498 | 86 630 | −0,57 | 266,64 | −132 787 | 23 099 023 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 250 | 87 128 | 7,73 | 21,25 | 132 812 | 1 851 470 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −23 730 | 80 878 | −22,68 | 266,64 | −6 327 367 | 21 565 310 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −3 984 | 104 608 | −3,67 | 266,64 | −1 062 294 | 27 892 677 |
2013-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 50 000 | 108 592 | 85,34 | 21,25 | 1 062 500 | 2 307 580 |
2013-01-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 58 592 | −0,34 | 174,56 | −34 912 | 10 227 820 |
2013-01-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 227 | 58 792 | −3,65 | 173,37 | −386 095 | 10 192 769 |
2013-01-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 200 | 61 019 | −3,48 | 172,77 | −380 094 | 10 542 253 |
2013-01-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 63 219 | −1,86 | 171,11 | −205 332 | 10 817 403 |
2013-01-17 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 051 | 64 419 | −3,09 | 170,57 | −349 839 | 10 987 949 |
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −1 850 | 3 071 | −37,59 | ||||
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −3 400 | 750 | −81,93 | ||||
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 850 | 66 470 | 2,86 | 20,32 | 37 592 | 1 350 670 | |
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 84 500 | 84 500 | |||||
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 56 250 | 79 670 | 240,18 | ||||
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −4 607 | 64 620 | −6,65 | 179,13 | −825 252 | 11 575 381 |
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −6 100 | 4 150 | −59,51 | ||||
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −4 250 | 10 250 | −29,31 | ||||
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | 14 500 | 14 500 | |||||
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −14 500 | 69 227 | −17,32 | ||||
2012-12-18 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −250 | 83 727 | −0,30 | ||||
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 83 977 | −0,83 | 149,18 | −104 426 | 12 527 689 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −900 | 84 677 | −1,05 | 148,65 | −133 785 | 12 587 236 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 556 | 85 577 | −1,79 | 147,65 | −229 743 | 12 635 444 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −4 745 | 0 | −100,00 | |||
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −3 431 | 0 | −100,00 | |||
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −792 | 87 133 | −0,90 | 148,05 | −117 256 | 12 900 041 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 845 | 87 925 | −4,19 | 147,62 | −567 599 | 12 979 488 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 400 | 91 770 | −1,50 | 146,58 | −205 212 | 13 451 647 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −300 | 93 170 | −0,32 | 145,65 | −43 695 | 13 570 210 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 93 470 | −0,21 | 144,36 | −28 872 | 13 493 329 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 489 | 93 670 | −1,56 | 146,60 | −218 287 | 13 732 022 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −198 | 95 159 | −0,21 | 146,60 | −29 027 | 13 950 309 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 431 | 95 357 | 3,73 | 8,50 | 29 164 | 810 534 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −1 205 | 91 926 | −1,29 | 146,60 | −176 653 | 13 476 352 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −2 128 | 93 131 | −2,23 | 146,60 | −311 965 | 13 653 005 |
2012-11-15 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 745 | 95 259 | 5,24 | 65,76 | 312 031 | 6 264 232 |
2012-09-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −476 | 90 514 | −0,52 | 147,21 | −70 072 | 13 324 566 |
2012-09-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 626 | 90 990 | −1,76 | 146,37 | −237 998 | 13 318 206 |
2012-09-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 691 | 92 616 | −2,82 | 145,60 | −391 810 | 13 484 890 |
2012-09-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −503 | 95 307 | −0,52 | 144,59 | −72 729 | 13 780 439 |
2012-09-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −600 | 95 810 | −0,62 | ||||
2012-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −4 562 | 0 | −100,00 | ||||
2012-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | −11 682 | 0 | −100,00 | ||||
2012-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 11 682 | 96 410 | 13,79 | 11,64 | 135 978 | 1 122 212 | |
2012-05-22 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | 4 562 | 84 728 | 5,69 | 21,92 | 99 999 | 1 857 238 | |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 80 166 | −0,12 | 138,48 | −13 848 | 11 101 388 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 80 266 | −0,86 | 137,19 | −96 033 | 11 011 693 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 211 | 80 966 | −4,94 | 136,34 | −574 128 | 11 038 904 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 265 | 85 177 | −6,85 | 135,60 | −849 534 | 11 550 001 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 294 | 91 442 | −7,39 | 134,47 | −980 824 | 12 296 206 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 872 | 98 736 | −5,61 | 133,51 | −783 971 | 13 182 243 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −200 | 104 608 | −0,19 | 132,96 | −26 592 | 13 908 680 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | X | 4 088 | 8 749 | 87,71 | |||
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | X | 4 661 | 4 661 | ||||
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −29 000 | 0 | −100,00 | |||
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −25 438 | 29 000 | −46,73 | |||
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −11 212 | 104 808 | −9,66 | 136,37 | −1 528 980 | 14 292 667 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −4 661 | 116 020 | −3,86 | 136,37 | −635 621 | 15 821 647 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 29 000 | 120 681 | 31,63 | 21,92 | 635 680 | 2 645 328 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −9 835 | 91 681 | −9,69 | 136,37 | −1 341 199 | 12 502 538 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −4 088 | 101 516 | −3,87 | 136,37 | −557 481 | 13 843 737 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 25 438 | 105 604 | 31,73 | 21,92 | 557 601 | 2 314 840 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 990 | 80 166 | −3,60 | 138,28 | −413 457 | 11 085 354 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 355 | 83 156 | −1,60 | 137,52 | −186 340 | 11 435 613 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −800 | 84 511 | −0,94 | 136,63 | −109 304 | 11 546 738 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −600 | 85 311 | −0,70 | 135,33 | −81 198 | 11 545 138 |
2012-05-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 200 | 85 911 | −1,38 | 134,64 | −161 568 | 11 567 057 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −500 | 87 111 | −0,57 | 101,35 | −50 675 | 8 828 700 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 735 | 87 611 | −4,09 | 100,42 | −375 069 | 8 797 897 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 265 | 91 346 | −12,68 | 99,67 | −1 322 123 | 9 104 456 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −12 788 | 0 | −100,00 | |||
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −9 375 | 23 420 | −28,59 | |||
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −18 750 | 69 048 | −21,36 | |||
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −4 400 | 104 611 | −4,04 | 98,23 | −432 212 | 10 275 939 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −3 236 | 109 011 | −2,88 | 98,23 | −317 872 | 10 708 151 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 788 | 112 247 | 12,86 | 24,86 | 317 910 | 2 790 460 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −3 384 | 99 459 | −3,29 | 98,23 | −332 410 | 9 769 858 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −2 027 | 102 843 | −1,93 | 98,23 | −199 112 | 10 102 268 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 375 | 104 870 | 9,82 | 21,25 | 199 219 | 2 228 488 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −7 160 | 95 495 | −6,97 | 98,23 | −703 327 | 9 380 474 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −3 206 | 102 655 | −3,03 | 98,23 | −314 925 | 10 083 801 |
2012-02-08 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 18 750 | 105 861 | 21,52 | 16,80 | 315 000 | 1 778 465 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 87 111 | −0,11 | 93,04 | −9 304 | 8 104 807 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 992 | 87 211 | −8,39 | 92,22 | −737 022 | 8 042 598 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 151 | 95 203 | −6,99 | 91,71 | −655 818 | 8 731 067 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 015 | 102 354 | −2,86 | 90,64 | −273 280 | 9 277 367 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | X | 3 893 | 3 893 | ||||
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | X | 6 334 | 6 334 | ||||
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −16 000 | 54 438 | −22,72 | |||
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −28 079 | 1 200 | −95,90 | |||
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −5 577 | 105 369 | −5,03 | 90,07 | −502 320 | 9 490 586 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −3 893 | 110 946 | −3,39 | 90,07 | −350 643 | 9 992 906 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 16 000 | 114 839 | 16,19 | 21,92 | 350 720 | 2 517 271 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −10 017 | 98 839 | −9,20 | 90,07 | −902 231 | 8 902 429 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −6 334 | 108 856 | −5,50 | 90,07 | −570 503 | 9 804 660 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 28 079 | 115 190 | 32,23 | 20,32 | 570 565 | 2 340 661 |
2012-02-02 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
G - Gift | −2 250 | 87 111 | −2,52 | ||||
2012-01-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −400 | 89 361 | −0,45 | 79,51 | −31 804 | 7 105 093 |
2012-01-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 216 | 89 761 | −3,46 | 78,17 | −251 395 | 7 016 617 |
2012-01-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 567 | 92 977 | −12,73 | 77,86 | −1 056 327 | 7 239 189 |
2012-01-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | X | 10 424 | 10 424 | ||||
2012-01-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −40 800 | 29 279 | −58,22 | |||
2012-01-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −13 193 | 106 544 | −11,02 | 79,53 | −1 049 239 | 8 473 444 |
2012-01-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −10 424 | 119 737 | −8,01 | 79,53 | −829 021 | 9 522 684 |
2012-01-23 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 40 800 | 130 161 | 45,66 | 20,32 | 829 056 | 2 644 872 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −492 | 36 516 | −1,33 | 14,94 | −7 350 | 545 549 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | X | −17 850 | 0 | −100,00 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −1 000 | 0 | −100,00 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −246 | 1 000 | −19,74 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −1 100 | 1 246 | −46,89 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −1 804 | 2 346 | −43,47 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −4 200 | 4 150 | −50,30 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −700 | 8 350 | −7,73 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −100 | 9 050 | −1,09 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −1 000 | 9 150 | −9,85 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −1 000 | 10 150 | −8,97 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) |
M - Exercise | X | −1 000 | 11 150 | −8,23 | |||
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −260 | 37 008 | −0,70 | 13,31 | −3 461 | 492 576 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
F - Taxes | X | −17 098 | 37 268 | −31,45 | 13,31 | −227 574 | 496 037 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 17 850 | 54 366 | 48,88 | 12,75 | 227 588 | 693 166 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 36 516 | −2,67 | 13,16 | −13 160 | 480 551 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 37 516 | 2,74 | 12,75 | 12 750 | 478 329 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −246 | 36 516 | −0,67 | 13,13 | −3 230 | 479 455 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 246 | 36 762 | 0,67 | 12,75 | 3 136 | 468 716 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 100 | 36 516 | −2,92 | 13,12 | −14 432 | 479 090 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 100 | 37 616 | 3,01 | 12,75 | 14 025 | 479 604 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 804 | 36 516 | −4,71 | 13,11 | −23 650 | 478 725 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 804 | 38 320 | 4,94 | 12,75 | 23 001 | 488 580 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 200 | 36 516 | −10,32 | 13,10 | −55 020 | 478 360 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 200 | 40 716 | 11,50 | 12,75 | 53 550 | 519 129 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −700 | 36 516 | −1,88 | 13,09 | −9 163 | 477 994 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 700 | 37 216 | 1,92 | 12,75 | 8 925 | 474 504 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 36 516 | −0,27 | 13,08 | −1 308 | 477 629 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 100 | 36 616 | 0,27 | 12,75 | 1 275 | 466 854 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 36 516 | −2,67 | 13,05 | −13 050 | 476 534 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 37 516 | 2,74 | 12,75 | 12 750 | 478 329 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 36 516 | −2,67 | 13,00 | −13 000 | 474 708 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 37 516 | 2,74 | 12,75 | 12 750 | 478 329 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 36 516 | −2,67 | 12,99 | −12 990 | 474 343 |
2005-12-28 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 37 516 | 2,74 | 12,75 | 12 750 | 478 329 |
2005-07-21 |
|
4 | REGN |
REGENERON PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 177 | 36 516 | −5,63 | 10,00 | −21 770 | 365 160 |